Targeting OX40-OX40L pathway: A new era in atopic dermatitis management by T cell rebalancing 🔗 Access full article via Journal of Allergy and Clinical ImmunologyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
